logo IDIBELL
Català  |   Castellano  |   English
Search
The InstituteResearchWhat's onPlatformsJoin usTools
 

News

boto imprimir
Date: 17/04/2018

Bringing research closer to the industry

IDIBELL celebrates the first edition of its Accelerator Meeting Point


The Bellvitge Biomedical Research Institute (IDIBELL) held yesterday April 16th the first edition of its Accelerator Meeting Point, a meeting where CataloniaBio -association of biomedicine and health companies in Catalonia-, Biocat -institution responsible for the promotion of the life sciences and health sector in Catalonia- and Health Equity -Venture capital of the Barcelona Medical Association- spent a day with researchers in order to provide recommendations for research projects at a stage two to three years prior to reaching a commercial milestone.

 

IDIBELL, as manager of part of the research carried out at the Bellvitge University Hospital, the Catalan Institute of Oncology and the University of Barcelona, ​​is aware of the need for company expertise to be included in the roadmap of a research project. "The Accelerator Meeting Point not only seeks to receive recommendations but also increases the knowledge that companies have about our research and the possibilities of local collaborations," says Raquel Egea, director of ​​innovation and business development area at IDIBELL.

 

 "One of the main problems in knowledge transfer in biomedical research centers is the limited amount of collaboration with the industry," explains Egea. "When moving from bench to bedside, companies will be in charge of the final development, production and marketing of the product. Taking this into account, the company expertise is essential to properly make an appraisal of a research project”, she adds.

 

Aspects such as the type of regulation that will affect the results, the budget of a clinical trial, the type of protection appropriate to each market or the marketing approach are some of the issues that participants could contrast with the company experts.

 

Despite being aware that "there is a lack of collaboration between research groups and companies compared to other countries”, the participating researchers said that "companies are precisely the ones that end up assessing all sorts of technical aspects in order to finally acquire a technology or not; it becomes obvious to us, then, to seek collaboration with them in the early stages of the transfer process, a process that already begins with basic research”.





foto IDIBELL celebrates the first edition of its Accelerator Meeting Point
IDIBELL celebrates the first edition of its Accelerator Meeting Point

Share/Bookmark
 
© 2018 Institut d'Investigació Biomèdica de Bellvitge



Results by pageInitial date
Select date
TitleFinal date
Select date
Search


Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept



Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept


Cancell

Passwords doesn’t match
The password must have at least 6 characters
The new password can not contain special characters
User register

Name
Surname
Second Surname
E-mail
User
Password
Language


Accept


Cancell




Encara no heu contestat l'enquesta de satisfacció sobre la píndola formativa sobre patents. No trigareu més de cinc minuts a fer-ho. La vostra opinió és molt important per millorar l’IDIBELL.

Voleu fer l’enquesta ara?

Yes

No




Further personal and contact information is needed to maintain IDIBELL databases.

Do you wish to fill the form now?

Yes

No





Please, remember to introduce your holiday’s planning in the application

Accept

Cancell